Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012459 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Emeline Barbieux und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unité de Recherche en Biologie des Microorganismes (URBM)-Laboratoire d'Immunologie et de Microbiologie, NARILIS, University of Namur, Namur, Belgium. Hauptthemen laut MEDLINE: Brucella melitensis, Brucellosis, Spleen, Brucella Vaccine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds National de la Recherche Scientifique (FNRS), FRS-FNRS (Belgium), Fonds De La Recherche Scientifique - FNRS.
Abstract (Originalsprache)
Live attenuated vaccines (LAVs) whose virulence would be controlled at the tissue level could be a crucial tool to effectively fight intracellular bacterial pathogens, because they would optimize the induction of protective immune memory while avoiding the long-term persistence of vaccine strains in the host. Rational development of these new LAVs implies developing an exhaustive map of the bacterial virulence genes according to the host organs implicated. We report here the use of transposon sequencing to compare the bacterial genes involved in the multiplication of Brucella melitensis , a major causative agent of brucellosis, in the lungs and spleens of C57BL/6 infected mice. We found 257 and 135 genes predicted to be essential for B . melitensis multiplication in the spleen and lung, respectively, with 87 genes common to both organs. We selected genes whose deletion is predicted to produce moderate or severe attenuation in the spleen, the main known reservoir of Brucella , and compared deletion mutants for these genes for their ability to protect mice against challenge with a virulent strain of B . melitensis . The protective efficacy of a deletion mutant for the plsC gene, implicated in phospholipid biosynthesis, is similar to that of the reference Rev.1 vaccine but with a shorter persistence in the spleen. Our results demonstrate that B . melitensis faces different selective pressures depending on the organ and underscore the effectiveness of functional genome mapping for the design of new safer LAV candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unité de Recherche en Biologie des Microorganismes (URBM)-Laboratoire d'Immunologie et de Microbiologie, NARILIS, University of Namur, Namur, Belgium.
- Laboratoire de Parasitologie, and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.
- Unité de recherche en physiologie moléculaire (URPhyM)-Laboratoire de Génétique moléculaire (GéMo), University of Namur, Namur, Belgium.
- Departamento de Microbiología y Parasitología - IDISNA, Universidad de Navarra, Pamplona, Spain.
ORCID-Profile: Eric Muraille
Förderung
- Fonds National de la Recherche Scientifique (FNRS)
- FRS-FNRS (Belgium)
- Fonds De La Recherche Scientifique - FNRS
Zitieren
APA
Barbieux, E., Potemberg, G., Stubbe, F. X., Fraikin, A., Poncin, K., Reboul, A., Rouma, T., Zúñiga-Ripa, A., De Bolle, X., & Muraille, E. (2024). Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012459
Vancouver
Barbieux E, Potemberg G, Stubbe FX, Fraikin A, Poncin K, Reboul A, et al. Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012459
BibTeX
@article{Barbieux2024,
author = {Barbieux, Emeline and Potemberg, Georges and Stubbe, François-Xavier and Fraikin, Audrey and Poncin, Katy and Reboul, Angeline and Rouma, Thomas and Zúñiga-Ripa, Amaia and De Bolle, Xavier and Muraille, Eric},
title = {Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012459}
}
EUVIMED